期刊
BRITISH JOURNAL OF ANAESTHESIA
卷 97, 期 5, 页码 681-686出版社
ELSEVIER SCI LTD
DOI: 10.1093/bja/ael240
关键词
sugammadex (Org 25969), reversal agent, rocuronium, neuromuscular block, time course of action
Background. Reversal of neuromuscular block can be accomplished by chemical encapsulation of rocuronium by sugammadex (Org 25969), a synthetic gamma-cyclodextrin derivative. The present study determined the time course of the reversal action of sugammadex on rocuronium-induced block in the anaesthetized Rhesus monkey using train-of-four stimulation. Methods. A bolus injection of rocuronium 100 mu g kg(-1) (about 1xED(90)) was given to determine the degree of neuromuscular block reached by this dose. After complete spontaneous recovery, a rapid bolus injection of sugammadex, 1 mg kg(-1), was given and at different time intervals (15, 30 or 60 min, in three different experiments) the effect of another rocuronium bolus injection of 100 mu g kg(-1) was determined. Results. Injection of the first dose of rocuronium resulted in a mean neuromuscular block (depression of first twitch) of 93 (sem=1.6)%. Fifteen minutes after injection of sugammadex the same rocuronium dose resulted in 17% (sem=5.6) block. After 30 and 60 min these maximum blocks amounted to 49% (sem=7.6) and 79% (sem=4.2), respectively. The estimated half-life of sugammadex in Rhesus monkey is 30 (sem=4.9) min. Conclusions. The half-life of sugammadex (Org 25969), a new fast and efficient reversal agent for rocuronium-induced block, is relatively short in the Rhesus monkey, implying the possibility to perform neuromuscular block by rocuronium shortly after reversal of a prior block. In translation to the human situation differences in rocuronium sensitivity and kinetics should be taken into account.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据